Vtv Therapeutics Inc (VTVT)

Apr 22, 2025

vTv Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:VTVT - Benzinga

Apr 22, 2025

Apr 16, 2025

vTv Therapeutics (NASDAQ:VTVT) Coverage Initiated at StockNews.com - Defense World

Apr 16, 2025

Apr 12, 2025

vTv Therapeutics Appoints Barry Brown as Interim CFO - MSN

Apr 12, 2025

Apr 11, 2025

vTv Therapeutics (NASDAQ:VTVT) Coverage Initiated at HC Wainwright - Defense World

Apr 11, 2025

Apr 11, 2025

Q1 Earnings Forecast for VTVT Issued By HC Wainwright - Defense World

Apr 11, 2025

Apr 09, 2025

HC Wainwright Initiates vTv Therapeutics With Buy Rating, $36 Price Target - MarketScreener

Apr 09, 2025

Apr 09, 2025

This Couchbase Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga

Apr 09, 2025

Apr 09, 2025

HC Wainwright & Co. Initiates Coverage of vTv Therapeutics (VTVT) with Buy Recommendation - Nasdaq

Apr 09, 2025

Apr 09, 2025

H.C. Wainwright sets $36 target for vTv Therapeutics stock By Investing.com - Investing.com Canada

Apr 09, 2025

Apr 09, 2025

H.C. Wainwright sets $36 target for vTv Therapeutics stock - Investing.com

Apr 09, 2025

Apr 04, 2025

(VTVT) Trading Advice - news.stocktradersdaily.com

Apr 04, 2025

Mar 27, 2025

vTv Therapeutics (NASDAQ:VTVT) Now Covered by StockNews.com - Defense World

Mar 27, 2025

Mar 25, 2025

(VTVT) Trading Signals - news.stocktradersdaily.com

Mar 25, 2025

Mar 21, 2025

vTv Therapeutics Inc Reports Q4 2024 EPS of -$0.55, Beating Esti - GuruFocus.com

Mar 21, 2025

Mar 21, 2025

vTv Therapeutics Announces 2024 Fourth Quarter and Full Year Financial Results and Provides Corporate Update - GlobeNewswire

Mar 21, 2025

Mar 21, 2025

The Zacks Analyst Blog Highlights Sarepta Therapeutics, Incyte, Gilead Sciences and VTv Therapeutics - Nasdaq

Mar 21, 2025

Mar 20, 2025

VTv Therapeutics: Q4 Earnings Snapshot - CTPost

Mar 20, 2025

Mar 20, 2025

vTv Therapeutics: A New Dawn for Diabetes Treatment? - AInvest

Mar 20, 2025

Mar 20, 2025

VTv Therapeutics: Q4 Earnings Snapshot -March 20, 2025 at 06:02 pm EDT - Marketscreener.com

Mar 20, 2025

Mar 20, 2025

vTv Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 20, 2025

Mar 20, 2025

FDA Greenlights vTv Diabetes Drug Trial as Cash Reserves Triple to $36.7M - StockTitan

Mar 20, 2025

Mar 20, 2025

vTv Therapeutics Inc. (VTVT) reports earnings - Quartz

Mar 20, 2025

Mar 20, 2025

Why Celsius Holdings Stock Popped This Week - The Globe and Mail

Mar 20, 2025

Mar 20, 2025

Biotech Stock Roundup: Patient Death Hits SRPT, INCY Study Data & More - Zacks Investment Research

Mar 20, 2025

Mar 20, 2025

Short Interest in vTv Therapeutics Inc. (NASDAQ:VTVT) Decreases By 13.6% - Defense World

Mar 20, 2025

Mar 19, 2025

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Mar 19, 2025

Mar 19, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Mar 19, 2025

Mar 19, 2025

StockNews.com Begins Coverage on vTv Therapeutics (NASDAQ:VTVT) - Defense World

Mar 19, 2025

Mar 17, 2025

vTv Therapeutics Soars 43% as FDA Lifts Clinical Hold on Diabetes Drug Trial - GuruFocus.com

Mar 17, 2025

Mar 17, 2025

Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup - MarketScreener

Mar 17, 2025

Mar 17, 2025

Sector Update: Health Care Stocks Rise Late Afternoon - TradingView

Mar 17, 2025

Mar 17, 2025

Sector Update: Health Care -March 17, 2025 at 03:39 pm EDT - Marketscreener.com

Mar 17, 2025

Mar 17, 2025

FDA Lifts Clinical Hold On vTv Therapeutics' Phase 3 Diabetes Trial, Stock Surges - Benzinga

Mar 17, 2025

Mar 17, 2025

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Mar 17, 2025

Mar 17, 2025

FDA Lifts Clinical Hold, vTv Therapeutics (VTVT) Stock Surges - Stocks Telegraph

Mar 17, 2025

Mar 17, 2025

vTv Therapeutics up after FDA lifts clinical hold on its oral diabetes treatment study - Seeking Alpha

Mar 17, 2025

Mar 17, 2025

vTv Therapeutics resumes phase 3 diabetes trial By Investing.com - Investing.com Australia

Mar 17, 2025

Mar 17, 2025

VTv Therapeutics Says FDA Lifted Clinical Hold On Cadisegliatin Program For Diabetes - Nasdaq

Mar 17, 2025

Mar 17, 2025

vTv Therapeutics stock surges on FDA update By Investing.com - Investing.com Canada

Mar 17, 2025

Mar 17, 2025

Vtv Therapeutics Says FDA Lifts Clinical Hold on Cadisegliatin Program for Diabetes; Shares Up Pre-Bell - Marketscreener.com

Mar 17, 2025

Mar 17, 2025

vTv Therapeutics stock surges on FDA update - Investing.com

Mar 17, 2025

Mar 17, 2025

vTv Therapeutics resumes phase 3 diabetes trial - Investing.com

Mar 17, 2025

Mar 17, 2025

vTv Therapeutics Announces Resumption of CATT1 Phase 3 Trial for Cadisegliatin as Potential First Oral Adjunct Therapy for Type 1 Diabetes - Nasdaq

Mar 17, 2025

Mar 17, 2025

vTv Therapeutics Announces FDA has Lifted Clinical Hold on Cadisegliatin Program for Diabetes - The Manila Times

Mar 17, 2025

Mar 17, 2025

FDA Green Light: vTv's Revolutionary Oral Diabetes Drug Back on Track with Faster Timeline - StockTitan

Mar 17, 2025

Mar 12, 2025

3 Quality Compounders on Our Buy List - The Globe and Mail

Mar 12, 2025